Dissecting Major Signaling Pathways throughout the Development of Prostate Cancer

scientific article published on 29 April 2013

Dissecting Major Signaling Pathways throughout the Development of Prostate Cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1155/2013/920612
P932PMC publication ID3657461
P698PubMed publication ID23738079
P5875ResearchGate publication ID237058052

P50authorLuiz ZerbiniQ72622624
P2093author name stringRicardo G Correa
Eduardo P Amaral
Carina C Jank
Eduardo L Nolasco
Henrique B da Silva
Nathalia C de Victo
Rodrigo Atique
Valesca Anschau
P2860cites workAck1 mediated AKT/PKB tyrosine 176 phosphorylation regulates its activationQ21142629
The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic inventionQ21245733
Wnt signaling pathways in urological cancers: past decades and still growingQ21245761
VEGF prevents apoptosis of human microvascular endothelial cells via opposing effects on MAPK/ERK and SAPK/JNK signalingQ22009049
The pro-apoptotic kinase Mst1 and its caspase cleavage products are direct inhibitors of Akt1Q24297392
MST1 is a multifunctional caspase-independent inhibitor of androgenic signalingQ24300132
Wnt-11 promotes neuroendocrine-like differentiation, survival and migration of prostate cancer cellsQ24302096
Selective interaction of JNK protein kinase isoforms with transcription factorsQ24317346
Phosphoinositide 3-kinase/Akt inhibits MST1-mediated pro-apoptotic signaling through phosphorylation of threonine 120Q24321602
Synergistic activation of stress-activated protein kinase 1/c-Jun N-terminal kinase (SAPK1/JNK) isoforms by mitogen-activated protein kinase kinase 4 (MKK4) and MKK7Q24532197
FZD4 as a mediator of ERG oncogene-induced WNT signaling and epithelial-to-mesenchymal transition in human prostate cancer cells.Q39666997
Common botanical compounds inhibit the hedgehog signaling pathway in prostate cancerQ39714349
AMP-activated protein kinase (AMPK) cross-talks with canonical Wnt signaling via phosphorylation of beta-catenin at Ser 552.Q39719643
Inhibiting TNF-mediated signaling: a novel therapeutic paradigm for androgen independent prostate cancerQ39784222
Critical role of Smad2 in tumor suppression and transforming growth factor-beta-induced apoptosis of prostate epithelial cellsQ39874700
Natural derivatives of curcumin attenuate the Wnt/beta-catenin pathway through down-regulation of the transcriptional coactivator p300.Q39918946
The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML networkQ39948774
Induction of the SUMO-specific protease 1 transcription by the androgen receptor in prostate cancer cellsQ40068850
GCP-mediated growth inhibition and apoptosis of prostate cancer cells via androgen receptor-dependent and -independent mechanismsQ40179207
Regulation of androgen receptor activity by tyrosine phosphorylation.Q40219614
Genomic Analysis Highlights the Role of the JAK-STAT Signaling in the Anti-proliferative Effects of Dietary Flavonoid-'Ashwagandha' in Prostate Cancer CellsQ40310152
Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis.Q40350197
Prostate cancer cells promote osteoblastic bone metastases through WntsQ40377933
MAPK/ERK signaling in activated T cells inhibits CD95/Fas-mediated apoptosis downstream of DISC assemblyQ40430386
C/EBPdelta is a downstream mediator of IL-6 induced growth inhibition of prostate cancer cellsQ40503739
E17K substitution in AKT1 in prostate cancerQ40528326
Distinct roles for the catalytic and hemopexin domains of membrane type 1-matrix metalloproteinase in substrate degradation and cell migrationQ40598211
An AU-rich element in the 3′ untranslated region of the C/EBPδ mRNA is important for protein binding during G0 growth arrestQ40652748
Attenuation of Ras signaling restores androgen sensitivity to hormone-refractory C4-2 prostate cancer cellsQ40654217
Mitogen-activated protein kinase kinase 4 (MKK4) acts as a metastasis suppressor gene in human ovarian carcinoma.Q40689238
Phosphatidylinositol 3-kinase/Akt stimulates androgen pathway through GSK3beta inhibition and nuclear beta-catenin accumulationQ40725486
Interleukin-6 induces prostate cancer cell growth accompanied by activation of stat3 signaling pathway .Q40905632
FGF8 over-expression in prostate cancer is associated with decreased patient survival and persists in androgen independent diseaseQ40951616
Interleukin-6: a candidate mediator of human prostate cancer morbidityQ41362792
Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factorQ41435735
Tgf-β1 produced by activated CD4(+) T Cells Antagonizes T Cell Surveillance of Tumor DevelopmentQ42204363
The MAPK/ERK cascade targets both Elk-1 and cAMP response element-binding protein to control long-term potentiation-dependent gene expression in the dentate gyrus in vivo.Q42488934
Immunohistochemical localization of interleukin-6 and its receptor in benign, premalignant and malignant prostate tissueQ42490034
MYC and Prostate CancerQ42731671
Alterations in beta-catenin expression and localization in prostate cancerQ42813475
Activation of p38 Mitogen-Activated Protein Kinase and c-Jun-NH2-Terminal Kinase by BMP-2 and Their Implication in the Stimulation of Osteoblastic Cell DifferentiationQ42834274
Accelerated in vivo growth of prostate tumors that up-regulate interleukin-6 is associated with reduced retinoblastoma protein expression and activation of the mitogen-activated protein kinase pathwayQ42855019
A prospective phase III randomized trial of hypofractionation versus conventional fractionation in patients with high-risk prostate cancerQ43202742
Promoter methylation in APC, RUNX3, and GSTP1 and mortality in prostate cancer patientsQ43430033
Co-operative functions between nuclear factors NFkappaB and CCAT/enhancer-binding protein-beta (C/EBP-beta) regulate the IL-6 promoter in autocrine human prostate cancer cellsQ45076496
KN-93 inhibits androgen receptor activity and induces cell death irrespective of p53 and Akt status in prostate cancerQ45225061
Activin A enhances prostate cancer cell migration through activation of androgen receptor and is overexpressed in metastatic prostate cancerQ46102160
Obesity and prostate cancer aggressiveness among African and Caucasian Americans in a population-based studyQ46895323
Gene expression analysis in prostate cancer: the importance of the endogenous control.Q47215788
Antitumor effects of the novel quinazolinone MJ-33: inhibition of metastasis through the MAPK, AKT, NF-κB and AP-1 signaling pathways in DU145 human prostate cancer cellsQ47350125
Prostate size and risk of high-grade, advanced prostate cancer and biochemical progression after radical prostatectomy: a search database studyQ47364687
Bone morphogenetic protein-10 suppresses the growth and aggressiveness of prostate cancer cells through a Smad independent pathwayQ47988622
On the rumors about the silent spring. Review of the scientific evidence linking occupational and environmental pesticide exposure to endocrine disruption health effectsQ34582049
Stat proteins and oncogenesisQ34627064
TGFbeta-SMAD signal transduction: molecular specificity and functional flexibilityQ34713446
A monoclonal antibody against Wnt-1 induces apoptosis in human cancer cellsQ34787867
Canonical and non-canonical JAK-STAT signalingQ34855617
The Wnt signalling pathwayQ34925309
Beta-catenin hits chromatin: regulation of Wnt target gene activationQ34967116
Hormonal, cellular, and molecular control of prostatic developmentQ35088639
A protein kinase C/protein kinase D pathway protects LNCaP prostate cancer cells from phorbol ester-induced apoptosis by promoting ERK1/2 and NF-{kappa}B activitiesQ35144545
Androgen receptor signaling in prostate cancer development and progressionQ35183663
Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and diseaseQ35452032
Environment and cancer in Brazil: an overview from a public health perspectiveQ35596052
Beta-catenin signaling in prostate cancer: an early perspectiveQ35624511
Effect of transforming growth factor beta (TGF-β) receptor I kinase inhibitor on prostate cancer bone growthQ35754279
Castration-resistant prostate cancer: systemic therapy in 2012Q35865011
IκB kinases modulate the activity of the androgen receptor in prostate carcinoma cell lines.Q35882191
MAP kinases and cell migrationQ35889220
Akt-mediated phosphorylation of Bmi1 modulates its oncogenic potential, E3 ligase activity, and DNA damage repair activity in mouse prostate cancer.Q35913650
Mechanism of β-catenin-mediated transcriptional regulation of epidermal growth factor receptor expression in glycogen synthase kinase 3 β-inactivated prostate cancer cellsQ36002945
Androgen receptor splice variants activate androgen receptor target genes and support aberrant prostate cancer cell growth independent of canonical androgen receptor nuclear localization signalQ36003940
Role of MMP-2 in the regulation of IL-6/Stat3 survival signaling via interaction with α5β1 integrin in gliomaQ36010641
Interleukin-6: from basic science to medicine--40 years in immunologyQ36072403
Changing demography of prostate cancer in AsiaQ36088800
Wnt signalling and prostate cancerQ36089054
Doxycycline regulated induction of AKT in murine prostate drives proliferation independently of p27 cyclin dependent kinase inhibitor downregulationQ36109815
Wnt signaling and injury repairQ36119516
Sabutoclax, a Mcl-1 antagonist, inhibits tumorigenesis in transgenic mouse and human xenograft models of prostate cancerQ36172754
Roles and regulation of Wnt signaling and beta-catenin in prostate cancerQ36197343
Proteomic profiling of androgen-independent prostate cancer cell lines reveals a role for protein S during the development of high grade and castration-resistant prostate cancerQ36298306
Oncogenic PI3K deregulates transcription and translationQ36337966
Risk factors for the onset of prostatic cancer: age, location, and behavioral correlatesQ36375316
Modulation of Akt/mTOR signaling overcomes sunitinib resistance in renal and prostate cancer cellsQ36378963
Role of Wnts in prostate cancer bone metastasesQ36382153
Handicapping the race to develop inhibitors of the phosphoinositide 3-kinase/Akt/mammalian target of rapamycin pathwayQ36391468
CCAAT/enhancer-binding proteins: structure, function and regulationQ24534323
Diet, supplement use, and prostate cancer risk: results from the prostate cancer prevention trialQ24594183
Cell signaling by receptor tyrosine kinasesQ24598357
Wnt modulators in the biotech pipelineQ24618567
AKT/PKB signaling: navigating downstreamQ24657857
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesisQ24681977
Pten dose dictates cancer progression in the prostateQ24791909
Cancer treatment and survivorship statistics, 2012Q27020961
Dietary flavonoid fisetin: a novel dual inhibitor of PI3K/Akt and mTOR for prostate cancer managementQ27026839
MYC cooperates with AKT in prostate tumorigenesis and alters sensitivity to mTOR inhibitorsQ27350187
The phosphoinositide 3-kinase pathwayQ27860738
Mechanisms of TGF-beta signaling from cell membrane to the nucleusQ27860785
Stem cells, cancer, and cancer stem cellsQ27860878
Interferon activation of the transcription factor Stat91 involves dimerization through SH2-phosphotyrosyl peptide interactionsQ28118180
TGFbeta signaling in growth control, cancer, and heritable disordersQ28142605
Role of transforming growth factor beta in human diseaseQ28143408
Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapyQ28176737
The ABC of APCQ28205388
Cancer susceptibility and the functions of BRCA1 and BRCA2Q28217784
Defining the role of mTOR in cancerQ28235431
Molecular determinants of resistance to antiandrogen therapyQ28236889
Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancerQ28267996
Signal transduction by the c-Jun N-terminal kinase (JNK)--from inflammation to developmentQ28268881
beta-catenin destruction complex: insights and questions from a structural perspectiveQ28276987
Integrating cell-signalling pathways with NF-kappaB and IKK functionQ28280069
Role of the STAT1-SH2 domain and STAT2 in the activation and nuclear translocation of STAT1Q28287881
TGFbeta in CancerQ28288866
The c-Fos protein interacts with c-Jun/AP-1 to stimulate transcription of AP-1 responsive genesQ28291126
The bottleneck of JNK signaling: molecular and functional characteristics of MKK4 and MKK7Q28305659
Targeted therapy for advanced prostate cancer: inhibition of the PI3K/Akt/mTOR pathwayQ28382812
Nuclear factor-kappaB/p65 (Rel A) is constitutively activated in human prostate adenocarcinoma and correlates with disease progressionQ28389404
Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I-induced signaling in an autochthonous mouse model of prostate cancer.Q50784946
Diet and mortality from common cancers in Brazil: an ecological study.Q51210262
Fibroblast growth factor receptor signaling through MEK-ERK is required for prostate bud induction.Q51765900
Expression of NF-κB-related proteins and their modulation during TNF-α-provoked apoptosis in prostate cancer cells.Q53251836
Inhibition of tumor growth and sensitization to chemotherapy by RNA interference targeting interleukin-6 in the androgen-independent human prostate cancer PC3 model.Q53277140
MAP2K4/MKK4 expression in pancreatic cancer: genetic validation of immunohistochemistry and relationship to disease course.Q53362092
Stat3 activation in prostatic carcinomas.Q53390466
Androgen metabolism and JAK/STAT pathway genes and prostate cancer risk.Q54514315
The P2Y2/Src/p38/COX-2 pathway is involved in the resistance to ursolic acid-induced apoptosis in colorectal and prostate cancer cells.Q54516019
The clinical effect of the dual-targeting strategy involving PI3K/AKT/mTOR and RAS/MEK/ERK pathways in patients with advanced cancer.Q54535188
Correlation analysis of JAK-STAT pathway components on prognosis of patients with prostate cancer.Q54580773
Notch-1 down-regulation by curcumin is associated with the inhibition of cell growth and the induction of apoptosis in pancreatic cancer cellsQ56749698
THE GENETICS OF BREAST CANCER SUSCEPTIBILITYQ57272243
Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic diseaseQ57908314
Interleukin-6 as a paracrine and autocrine growth factor in human prostatic carcinoma cells in vitroQ71955600
Detection and analysis of beta-catenin mutations in prostate cancerQ73260044
Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouseQ73435294
The Lynch Syndrome: Melding Natural History and Molecular Genetics to Genetic Counseling and Cancer ControlQ73821909
Immunoexpression of tumour necrosis factor-alpha and its receptors 1 and 2 correlates with proliferation/apoptosis equilibrium in normal, hyperplasic and carcinomatous human prostateQ73904625
Preoperative plasma levels of transforming growth factor beta(1) (TGF-beta(1)) strongly predict progression in patients undergoing radical prostatectomyQ73959218
Characterization of the role of IL-6 in the progression of prostate cancerQ74587530
Transforming growth factor beta1 is associated with angiogenesis, metastasis, and poor clinical outcome in prostate cancerQ77164555
Signaling by the cytokine receptor superfamilyQ77934807
The antiapoptotic effect of IL-6 autocrine loop in a cellular model of advanced prostate cancer is mediated by Mcl-1Q79314186
Ras-MEK-ERK signaling cascade regulates androgen receptor element-inducible gene transcription and DNA synthesis in prostate cancer cellsQ80114515
Pro-inflammatory cytokines and prostate-specific antigen in hyperplasia and human prostate cancerQ81050246
Classical and alternative nuclear factor-κB pathways: a comparison among normal prostate, benign prostate hyperplasia and prostate cancerQ83887156
The anti-interleukin-6 antibody siltuximab down-regulates genes implicated in tumorigenesis in prostate cancer patients from a phase I studyQ34025763
Identification of the miR-106b~25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformationQ34109986
Cytokine signaling in 2002: new surprises in the Jak/Stat pathwayQ34126053
IL-6 in autoimmune disease and chronic inflammatory proliferative diseaseQ34148654
The relationship between the roles of BRCA genes in DNA repair and cancer predispositionQ34163219
Posttranscriptional and posttranslational regulation of C/EBP delta in G0 growth-arrested mammary epithelial cellsQ34173442
NF-kappa B activates prostate-specific antigen expression and is upregulated in androgen-independent prostate cancerQ34277988
Potentiation of inflammatory CXCL8 signalling sustains cell survival in PTEN-deficient prostate carcinoma.Q34289623
Androgen deprivation induces senescence characteristics in prostate cancer cells in vitro and in vivoQ34295241
The JAK/STAT signaling pathwayQ34305849
New complexities for BRCA1 and BRCA2.Q34348715
Dietary soy and tea mitigate chronic inflammation and prostate cancer via NFκB pathway in the Noble rat modelQ34372606
Lysophosphatidic acid enhances vascular endothelial growth factor-C expression in human prostate cancer PC-3 cells.Q34387665
PKB/AKT: functional insights from genetic modelsQ34389540
Biological and clinical significance of the JAK-STAT pathway; lessons from knockout mice.Q34403348
New strategies for immunosuppression: interfering with cytokines by targeting the Jak/Stat pathway.Q34412332
Androgen receptor signaling in androgen-refractory prostate cancerQ34444942
Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control studyQ34473008
NFkappaB pathway: a good signaling paradigm and therapeutic targetQ36502786
Does sunlight prevent cancer? A systematic reviewQ36563815
STAT3 as a central mediator of neoplastic cellular transformationQ36665485
Transgenic Wnt/TCF pathway reporters: all you need is Lef?Q36672673
Expression of the epidermal growth factor receptor family in prostate carcinoma before and during androgen-independenceQ36696600
The many ways of Wnt in cancerQ36701583
Concise review: regulation of embryonic stem cell lineage commitment by mitogen-activated protein kinasesQ36705821
Inhibition of Akt pathways in the treatment of prostate cancerQ36807494
Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse modelQ36841356
The role of the BRCA2 gene in susceptibility to prostate cancer revisitedQ36924831
Curcumin inhibits Akt/mammalian target of rapamycin signaling through protein phosphatase-dependent mechanismQ37001348
The diverse and contrasting effects of using human prostate cancer cell lines to study androgen receptor roles in prostate cancerQ37074725
Small ubiquitin-like modifier protein-specific protease 1 and prostate cancerQ37074734
Suppression of Wnt/beta-catenin signaling inhibits prostate cancer cell proliferationQ37086749
The MAPK pathway in melanomaQ37094897
Biology and significance of the JAK/STAT signalling pathwaysQ37146441
Circulating prediagnostic interleukin-6 and C-reactive protein and prostate cancer incidence and mortalityQ37155349
Prostate development: a historical perspectiveQ37156817
Intracellular mechanisms of metabolism regulation: the role of signaling via the mammalian target of rapamycin pathway and other routes.Q37178247
Molecular alterations in prostate cancerQ37191507
Prevalence of aberrant expression of the epidermal growth factor receptor in human cancersQ37220614
Does prostate cancer co-opt the developmental program?Q37254510
Deciphering the function of canonical Wnt signals in development and disease: conditional loss- and gain-of-function mutations of beta-catenin in miceQ37259094
NF-kappaB regulates androgen receptor expression and prostate cancer growthQ37278416
Oncogenic activation of androgen receptorQ37359265
PIKKing on PKB: regulation of PKB activity by phosphorylationQ37419888
FGFR2 abnormalities underlie a spectrum of bone, skin, and cancer pathologiesQ37456169
Signal integration by JNK and p38 MAPK pathways in cancer developmentQ37560607
Gambogic acid inhibits TNF-α-induced invasion of human prostate cancer PC3 cells in vitro through PI3K/Akt and NF-κB signaling pathwaysQ37729931
Wnt signaling in stem and cancer stem cellsQ37788360
NFκB/p53 crosstalk-a promising new therapeutic target.Q37800637
Tyrosine-kinase inhibitors in the treatment of muscle invasive bladder cancer and hormone refractory prostate cancerQ37811705
Steps in prostate cancer progression that lead to bone metastasisQ37848782
Increased androgen receptor transcription: a cause of castration-resistant prostate cancer and a possible therapeutic target.Q37866912
Oxidative stress and androgen receptor signaling in the development and progression of castration-resistant prostate cancerQ37912413
A novel inhibitor of hypoxia-inducible factor-1α P3155 also modulates PI3K pathway and inhibits growth of prostate cancer cellsQ28394160
Inactivation of Apc in the mouse prostate causes prostate carcinomaQ28508948
Pten is essential for embryonic development and tumour suppressionQ28509238
Fibroblast growth factor receptor 2 tyrosine kinase is required for prostatic morphogenesis and the acquisition of strict androgen dependency for adult tissue homeostasisQ28512592
FGF-10 plays an essential role in the growth of the fetal prostateQ28513689
Role of epithelial cell fibroblast growth factor receptor substrate 2alpha in prostate development, regeneration and tumorigenesisQ28588423
Perifosine, a novel alkylphospholipid, inhibits protein kinase B activationQ28638584
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolismQ29547302
STATs and gene regulationQ29547796
The phosphatidylinositol 3-Kinase AKT pathway in human cancerQ29547860
The STATs of cancer--new molecular targets come of ageQ29614601
Wnt proteins are lipid-modified and can act as stem cell growth factorsQ29615009
TGF-beta signaling in tumor suppression and cancer progressionQ29615427
The functions and regulation of the PTEN tumour suppressorQ29615536
MAP kinase signalling pathways in cancerQ29615542
Proximal events in Wnt signal transductionQ29616162
Crosstalk in NF-κB signaling pathwaysQ29617418
Synergistic activation of stress-activated protein kinase 1/c-Jun N-terminal kinase (SAPK1/JNK) isoforms by mitogen-activated protein kinase kinase 4 (MKK4) and MKK7Q29999265
Androgen receptor phosphorylation. Regulation and identification of the phosphorylation sitesQ30309352
M-HIFU inhibits tumor growth, suppresses STAT3 activity and enhances tumor specific immunity in a transplant tumor model of prostate cancerQ30465410
Activation of mitogen-activated protein kinase associated with prostate cancer progression.Q30473093
K-ras and Wnt signaling synergize to accelerate prostate tumorigenesis in the mouseQ30856712
TGF-beta signaling: positive and negative effects on tumorigenesisQ31034737
Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complexQ31038919
Constitutive activation of JAK-STAT3 signaling by BRCA1 in human prostate cancer cellsQ31864260
Prostate cancer cell adhesion to bone marrow endothelium: the role of prostate-specific antigenQ33199699
JAK/STAT-dependent gene regulation by cytokines.Q33220017
BRAF activation initiates but does not maintain invasive prostate adenocarcinomaQ33392719
Effective prostate cancer chemopreventive intervention with green tea polyphenols in the TRAMP model depends on the stage of the diseaseQ33416685
Gene expression relationship between prostate cancer cells of Gleason 3, 4 and normal epithelial cells as revealed by cell type-specific transcriptomesQ33519740
Role of IAPs in prostate cancer progression: immunohistochemical study in normal and pathological (benign hyperplastic, prostatic intraepithelial neoplasia and cancer) human prostateQ33524557
Activation of the Akt survival pathway contributes to TRAIL resistance in cancer cellsQ33564264
Transcription factor Stat3 stimulates metastatic behavior of human prostate cancer cells in vivo, whereas Stat5b has a preferential role in the promotion of prostate cancer cell viability and tumor growth.Q33745272
Androgen-induced cell migration: role of androgen receptor/filamin A associationQ33831959
A constitutively activated form of the p110beta isoform of PI3-kinase induces prostatic intraepithelial neoplasia in miceQ33934457
Interleukin-6 and prostate cancer progressionQ33943225
Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanomaQ33992803
CTNNB1 mutation analysis is a useful tool for the diagnosis of desmoid tumors: a study of 260 desmoid tumors and 191 potential morphologic mimicsQ84529552
Breast cancer in a BRCA2 mutation carrier with a history of prostate cancerQ84592928
Non-canonical NF-κB signaling activation and regulation: principles and perspectivesQ37948121
NF-κB signaling in prostate cancer: a promising therapeutic target?Q37956492
A critical analysis of the long-term impact of radical prostatectomy on cancer control and function outcomesQ37968375
Androgen receptor (AR) aberrations in castration-resistant prostate cancer.Q37975896
The Jak/STAT pathwayQ37989935
Environmental exposures and prostate cancerQ37990121
Androgen action and metabolism in prostate cancerQ37997571
Perspectives on mTOR inhibitors for castration-refractory prostate cancer.Q38029399
Antitumor activity of NF-kB decoy oligodeoxynucleotides in a prostate cancer cell line.Q38327864
Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormoneQ38339139
IL-6 triggers cell growth via the Ras-dependent mitogen-activated protein kinase cascade.Q38343244
International variation in prostate cancer incidence and mortality rates.Q38935652
Autophagy modulators sensitize prostate epithelial cancer cell lines to TNF-alpha-dependent apoptosisQ39290799
SPRY2 loss enhances ErbB trafficking and PI3K/AKT signalling to drive human and mouse prostate carcinogenesisQ39339428
Oxidative stress and prostate cancer progression are elicited by membrane-type 1 matrix metalloproteinaseQ39362236
The AKT/NF-κB inhibitor xanthohumol is a potent anti-lymphocytic leukemia drug overcoming chemoresistance and cell infiltration.Q39374501
Role and regulation of STAT3 phosphorylation at Ser727 in melanocytes and melanoma cellsQ39379627
Hypoxia-induced up-regulation of aquaporin-1 protein in prostate cancer cells in a p38-dependent mannerQ39380390
High levels of p110δ PI3K expression in solid tumor cells suppress PTEN activity, generating cellular sensitivity to p110δ inhibitors through PTEN activationQ39385359
Increased TGF-β1-mediated suppression of growth and motility in castrate-resistant prostate cancer cells is consistent with Smad2/3 signalingQ39415532
Mitogen-activated protein kinase kinase kinase 1 activates androgen receptor-dependent transcription and apoptosis in prostate cancerQ39446502
GDC-0980 is a novel class I PI3K/mTOR kinase inhibitor with robust activity in cancer models driven by the PI3K pathwayQ39458307
β-Caryophyllene oxide inhibits growth and induces apoptosis through the suppression of PI3K/AKT/mTOR/S6K1 pathways and ROS-mediated MAPKs activationQ39472593
Overexpression of androgen receptor enhances the binding of the receptor to the chromatin in prostate cancerQ39475898
Elevated levels of circulating interleukin-6 and transforming growth factor-beta1 in patients with metastatic prostatic carcinomaQ39487932
CCI-779 inhibits cell-cycle G2-M progression and invasion of castration-resistant prostate cancer via attenuation of UBE2C transcription and mRNA stabilityQ39540207
Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancerQ39541646
Expression of nodal and nodal receptors in prostate stem cells and prostate cancer cells: autocrine effects on cell proliferation and migrationQ39545341
Expression profile of WNT molecules in prostate cancer and its regulation by aminobisphosphonates.Q39587433
Induction of apoptosis and inhibition of PI3K/Akt pathway in PC-3 and LNCaP prostate cancer cells by ethanolic neem leaf extractQ39601021
Characterization of soy-based changes in Wnt-frizzled signaling in prostate cancer.Q39643199
P275copyright licenseCreative Commons Attribution 3.0 UnportedQ14947546
P6216copyright statuscopyrightedQ50423863
P921main subjectprostate cancerQ181257
P304page(s)920612
P577publication date2013-04-29
P1433published inProstate CancerQ26842072
P1476titleDissecting Major Signaling Pathways throughout the Development of Prostate Cancer
P478volume2013

Reverse relations

cites work (P2860)
Q42115437A novel microRNA-1207-3p/FNDC1/FN1/AR regulatory pathway in prostate cancer
Q28817152Combined genetic and epigenetic interferences with interferon signaling expose prostate cancer cells to viral infection
Q38160495Disruption of prostate epithelial differentiation pathways and prostate cancer development
Q60955174Drosophila Jak/STAT Signaling: Regulation and Relevance in Human Cancer and Metastasis
Q36331604Identification of shared and unique susceptibility pathways among cancers of the lung, breast, and prostate from genome-wide association studies and tissue-specific protein interactions
Q49210539Interleukin-6 and Interferon-α Signaling via JAK1-STAT Differentially Regulate Oncolytic versus Cytoprotective Antiviral States.
Q37297497Lycopene inhibits the cell proliferation and invasion of human head and neck squamous cell carcinoma
Q38918320MAPK and JAK/STAT pathways targeted by miR-23a and miR-23b in prostate cancer: computational and in vitro approaches.
Q50573927Maternal Obesity, Cage Density, and Age Contribute to Prostate Hyperplasia in Mice.
Q90048237Mechanism of Anti-Cancer Activity of Curcumin on Androgen-Dependent and Androgen-Independent Prostate Cancer
Q38709756Mechanotransduction-Induced Reversible Phenotypic Switching in Prostate Cancer Cells
Q64963067MicroRNA-30e inhibits adhesion, migration, invasion and cell cycle progression of prostate cancer cells via inhibition of the activation of the MAPK signaling pathway by downregulating CHRM3.
Q64062289NOD-like receptors: major players (and targets) in the interface between innate immunity and cancer
Q46537204Prostate cancer health disparities: An immuno-biological perspective
Q37082974Reciprocal regulation of long noncoding RNAs THBS4‑003 and THBS4 control migration and invasion in prostate cancer cell lines
Q35758944Relative mRNA expression of prostate-derived E-twenty-six factor and E-twenty-six variant 4 transcription factors, and of uridine phosphorylase-1 and thymidine phosphorylase enzymes, in benign and malignant prostatic tissue
Q34482912Sex hormone-dependent tRNA halves enhance cell proliferation in breast and prostate cancers.
Q33688960The NLR-related protein NWD1 is associated with prostate cancer and modulates androgen receptor signaling.
Q91943954The Prospect of Identifying Resistance Mechanisms for Castrate-Resistant Prostate Cancer Using Circulating Tumor Cells: Is Epithelial-to-Mesenchymal Transition a Key Player?
Q35229964WMAXC: a weighted maximum clique method for identifying condition-specific sub-network

Search more.